007460 — Aprogen Share Price
Last trade - 00:00- KR₩352bn
- KR₩706bn
- KR₩151bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.38 | ||
| Price to Tang. Book | 3.33 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.34 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -19.73% | ||
| Return on Equity | -30.65% | ||
| Operating Margin | -61.42% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 78,248.84 | 127,142.62 | 141,247 | 78,349.31 | 150,577.98 | n/a | n/a | 24.15% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aprogen Inc, formerly Aprogen Medicines Inc, is a Korea-based company mainly engaged in the business of hardfacing. The Company operates its business through six segments. The Hardfacing segment is engaged in the provision of hardfacing for maintenance of steel mills, thermal power plants and cement plants. The Steel Sale segment is engaged in the sale of steel products, aluminum ingots and others. The Insulation segment is engaged in the nuclear thermal insulation and insulation construction. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceuticals. The Game segment is engaged in the mobile game publishing business. The Other segment is engaged in the sale of scrap metal.
Directors
- Won Seop Byun CEO (55)
- Jun Ho Jang VPR (60)
- Taek Hong Kang OTH (53)
- Gwang Yil Lee OTH (72)
- Chang Guk Yoon OTH (65)
- Jae Han Lee DRC (48)
- Seong Ju Moon DRC (58)
- Bong Hun Kim NID (55)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 15th, 1971
- Public Since
- July 8th, 1995
- No. of Employees
- 114
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
- Korea Exchange - KSE
- Shares in Issue
- 244,078,580
- Address
- Nara Tower, SEONGNAM, 13215
- Web
- https://www.aprogen-kic.com/
- Phone
- +82 316254045
- Auditors
- Indeok Accounting Corporation
Upcoming Events for 007460
Similar to 007460
Cheil Grinding Wheel Ind Co
Korea Exchange - KSE
CS Holdings Co
Korea Exchange - KSE
Daechang Forging Co
Korea Exchange - KSE
Daedong
Korea Exchange - KSE
Daewon Cable Co
Korea Exchange - KSE
FAQ
As of Today at 19:02 UTC, shares in Aprogen are trading at KR₩1,442. This share price information is delayed by 15 minutes.
Shares in Aprogen last closed at KR₩1,442 and the price had moved by +3.15% over the past 365 days. In terms of relative price strength the Aprogen share price has outperformed the FTSE Developed Asia Pacific Index by +7.66% over the past year.
There is no consensus recommendation for this security.
Aprogen does not currently pay a dividend.
Aprogen does not currently pay a dividend.
Aprogen does not currently pay a dividend.
To buy shares in Aprogen you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩1,442, shares in Aprogen had a market capitalisation of KR₩352bn.
Here are the trading details for Aprogen:
- Country of listing: Korea, Republic of
- Exchange: KSC
- Ticker Symbol: 007460
Based on an overall assessment of its quality, value and momentum Aprogen is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aprogen. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +29.36%.
As of the last closing price of KR₩1,442, shares in Aprogen were trading +15.6% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Aprogen PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩1,442.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Aprogen's management team is headed by:
- Won Seop Byun - CEO
- Jun Ho Jang - VPR
- Taek Hong Kang - OTH
- Gwang Yil Lee - OTH
- Chang Guk Yoon - OTH
- Jae Han Lee - DRC
- Seong Ju Moon - DRC
- Bong Hun Kim - NID